P3.02c-040 Checkmate 384: A Phase 3B/4 Dose-Frequency Optimization Trial of Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Harris, Ronald, Reinmuth, Niels, Mitchell, Paul, Zhu, Jin, Chang, I-Fen, Pichon, EricТом:
12
Мова:
english
Журнал:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.1835
Date:
January, 2017
Файл:
PDF, 172 KB
english, 2017